This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.
Building on the success of previous conferences, the theme of the 2013 meeting ‘Achieving Optimal Outcomes Through Multidisciplinary Care’ will reflect the need for collaboration and cooperation in producing the best possible outcomes in the treatment of lung cancer. It is also a reflection of the nature of the International Association for the Study of Lung Cancer which welcomes and encourages the participation of individuals from a wide range of professional backgrounds in its Conferences.
The conference series on Bioactive Lipids in Cancer, Inflammation and Related Diseases was started in 1989 when its first conference was held in Detroit, Michigan. Subsequent meetings were held around the globe with the next conference scheduled for November 3 - 6, 2013 in San Juan, Puerto Rico.
The previous biennial conferences have been immensely successful in highlighting data from research at the cutting edge of science on the role of lipid mediators in various physiological and pathological processes. The goal of this meeting series is to promote the exchange of ideas between scientists of diverse backgrounds from around the world. And to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflammation and inflammation induced diseases such as cardiovascular, diabetes, psoriasis, and Alzheimer's.